Who owns SAB Biotherapeutics Inc?

SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Sioux Falls, SD. SABS | Complete SAB Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Should you buy SAB Biotherapeutics (SABS) stock?

According to the issued ratings of 2 analysts in the last year, the consensus rating for SAB Biotherapeutics stock is Buy based on the current 2 buy ratings for SABS. The average twelve-month price prediction for SAB Biotherapeutics is $3.67 with a high price target of $4.00 and a low price target of $3.00.

What was the closing price of SAB Biotherapeutics Inc registered SHS?

On Wednesday 01/03/2024 the closing price of the SAB Biotherapeutics Inc Registered Shs share was $0.64 on BTT. Compared to the opening price on Wednesday 01/03/2024 on BTT of $0.69, this is a drop of 7.76%. SAB Biotherapeutics Inc Registered Shs's market capitalization is $59.91 M by 92.26 M shares outstanding.

The World's Leading Crypto Trading Platform

Get my welcome gifts